BHLHE40 and familial pancreatic carcinoma: High expression of BHLHE40 is significantly correlated with the activation of a hypoxia-response pathway, elevated metastatic potential, and a poor prognosis in many tumours, such as HCC, pancreatic cancer, and invasive breast cancer [28–30].